Plant sources of anti-cancer agents are plants, the derivatives of which have been shown to be usable for the treatment or prevention of cancer in humans. [1] [2]
Background
In the 1950s, scientists began systematically examining natural organisms as a source of useful anti-cancer substances. [1] It has been argued that "the use of natural products has been the single most successful strategy in the discovery of novel medicines". [3]
Plants need to defend themselves from attack by micro-organisms, in particular fungi, and they do this by producing anti-fungal chemicals that are toxic to fungi. Because fungal and human cells are similar at a biochemical level it is often the case that chemical compounds intended for plant defence have an inhibitory effect on human cells, including human cancer cells. [4] Those plant chemicals that are selectively more toxic to cancer cells than normal cells have been discovered in screening programs and developed as chemotherapy drugs [5]
Research and development process
Some plants that indicate potential as an anticancer agent in laboratory-based in vitro research – for example, Typhonium flagelliforme,[ citation needed] and Murraya koenigii [6] are currently being studied. There can be many years between promising laboratory work and the availability of an effective anti-cancer drug: Monroe Eliot Wall discovered anti-cancer properties in Camptotheca in 1958, but it was not until 1996 – after further research and rounds of clinical trials – that topotecan, a synthetic derivative of a chemical in the plant, was approved for use by the US Food and Drug Administration. [7]
Plants
- Camptotheca acuminata
The cancer treatment drug topotecan is a synthetic chemical compound similar in chemical structure to camptothecin which is found in extracts of Camptotheca (happy tree). [7]
- Catharanthus roseus
Vinca alkaloids were originally manufactured by extracting them from Catharanthus (Madagascar Periwinkle). [1]
- Podophyllum spp.
Two chemotherapy drugs, etoposide and teniposide, are synthetic chemical compounds similar in chemical structure to the toxin podophyllotoxin which is found in Podophyllum peltatum (May Apple). [1]
- Taxus brevifolia
Chemicals extracted from clippings of Taxus brevifolia (Pacific yew) have been used as the basis for two chemotherapy drugs, docetaxel and paclitaxel. [8]
- Euphorbia peplus
Contains ingenol mebutate (Picato) which is used to treat skin cancer [9]
- Maytenus ovatus
Trastuzumab emtansine (Kadcyla) is an antibody conjugated to a synthetic derivative of the cytotoxic principle of the Ethiopian plant Maytenus ovatus. It used to treat breast cancer. [10]
Mappia foetida
Some of the research has been showed that it has an effective anticancer property against breast cancer [1]
See also
- Herbal medicine
- Experimental cancer treatments
- Chemotherapy regimens
- National Comprehensive Cancer Network
- Alternative cancer treatments
References
- ^ a b c d Cragg, Gordon M.; Newman, David J. (2005). "Plants as a source of anti-cancer agents". Journal of Ethnopharmacology. 100 (1–2): 72–9. doi: 10.1016/j.jep.2005.05.011. PMID 16009521. Archived from the original on 2019-08-16. Retrieved 2019-09-16.
- ^ Shoeb, Mohammad (2008). "Anticancer agents from medicinal plants". Bangladesh Journal of Pharmacology. 1 (2). doi: 10.3329/bjp.v1i2.486.
- ^ Tulp, Martin; Bohlin, Lars (2002). "Functional versus chemical diversity: Is biodiversity important for drug discovery?". Trends in Pharmacological Sciences. 23 (5): 225–31. doi: 10.1016/S0165-6147(02)02007-2. PMID 12008000.
- ^ Cardenas, ME; Cruz, MC; Del Poeta, M; Chung, N; Perfect, JR; Heitman, J (1999). "Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action". Clin. Microbiol. Rev. 12 (4): 583–611. doi: 10.1128/CMR.12.4.583. PMC 88926. PMID 10515904.
- ^ "Discovery of Camptothecin and Taxol - National Historic Chemical Landmark". Archived from the original on 2015-06-20. Retrieved 2015-06-20.
- ^ Syam, Suvitha; Abdul, Ahmad Bustamam; Sukari, Mohd. Aspollah; Mohan, Syam; Abdelwahab, Siddig Ibrahim; Wah, Tang Sook (2011). "The Growth Suppressing Effects of Girinimbine on Hepg2 Involve Induction of Apoptosis and Cell Cycle Arrest". Molecules. 16 (8): 7155–70. doi: 10.3390/molecules16087155. PMC 6264672. PMID 21862957.
- ^ a b "Topotecan (NSC 609699)". National Cancer Institute. Archived from the original on May 27, 2010. Retrieved August 27, 2013.
- ^ "Yew clippings to make chemotherapy". Cancer Research UK. Archived from the original on September 8, 2022. Retrieved August 27, 2013.
- ^ Zarchi, K; Jemec, G. B. (2015). "Ingenol Mebutate: From Common Weed to Cancer Cure". Actinic Keratosis. Current Problems in Dermatology. Vol. 46. pp. 136–42. doi: 10.1159/000366549. ISBN 978-3-318-02762-4. PMID 25561218.
- ^ Peddi, P. F.; Hurvitz, S. A. (2014). "Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: Latest evidence and clinical potential". Therapeutic Advances in Medical Oncology. 6 (5): 202–209. doi: 10.1177/1758834014539183. PMC 4206612. PMID 25342987.
External links
Plant sources of anti-cancer agents are plants, the derivatives of which have been shown to be usable for the treatment or prevention of cancer in humans. [1] [2]
Background
In the 1950s, scientists began systematically examining natural organisms as a source of useful anti-cancer substances. [1] It has been argued that "the use of natural products has been the single most successful strategy in the discovery of novel medicines". [3]
Plants need to defend themselves from attack by micro-organisms, in particular fungi, and they do this by producing anti-fungal chemicals that are toxic to fungi. Because fungal and human cells are similar at a biochemical level it is often the case that chemical compounds intended for plant defence have an inhibitory effect on human cells, including human cancer cells. [4] Those plant chemicals that are selectively more toxic to cancer cells than normal cells have been discovered in screening programs and developed as chemotherapy drugs [5]
Research and development process
Some plants that indicate potential as an anticancer agent in laboratory-based in vitro research – for example, Typhonium flagelliforme,[ citation needed] and Murraya koenigii [6] are currently being studied. There can be many years between promising laboratory work and the availability of an effective anti-cancer drug: Monroe Eliot Wall discovered anti-cancer properties in Camptotheca in 1958, but it was not until 1996 – after further research and rounds of clinical trials – that topotecan, a synthetic derivative of a chemical in the plant, was approved for use by the US Food and Drug Administration. [7]
Plants
- Camptotheca acuminata
The cancer treatment drug topotecan is a synthetic chemical compound similar in chemical structure to camptothecin which is found in extracts of Camptotheca (happy tree). [7]
- Catharanthus roseus
Vinca alkaloids were originally manufactured by extracting them from Catharanthus (Madagascar Periwinkle). [1]
- Podophyllum spp.
Two chemotherapy drugs, etoposide and teniposide, are synthetic chemical compounds similar in chemical structure to the toxin podophyllotoxin which is found in Podophyllum peltatum (May Apple). [1]
- Taxus brevifolia
Chemicals extracted from clippings of Taxus brevifolia (Pacific yew) have been used as the basis for two chemotherapy drugs, docetaxel and paclitaxel. [8]
- Euphorbia peplus
Contains ingenol mebutate (Picato) which is used to treat skin cancer [9]
- Maytenus ovatus
Trastuzumab emtansine (Kadcyla) is an antibody conjugated to a synthetic derivative of the cytotoxic principle of the Ethiopian plant Maytenus ovatus. It used to treat breast cancer. [10]
Mappia foetida
Some of the research has been showed that it has an effective anticancer property against breast cancer [1]
See also
- Herbal medicine
- Experimental cancer treatments
- Chemotherapy regimens
- National Comprehensive Cancer Network
- Alternative cancer treatments
References
- ^ a b c d Cragg, Gordon M.; Newman, David J. (2005). "Plants as a source of anti-cancer agents". Journal of Ethnopharmacology. 100 (1–2): 72–9. doi: 10.1016/j.jep.2005.05.011. PMID 16009521. Archived from the original on 2019-08-16. Retrieved 2019-09-16.
- ^ Shoeb, Mohammad (2008). "Anticancer agents from medicinal plants". Bangladesh Journal of Pharmacology. 1 (2). doi: 10.3329/bjp.v1i2.486.
- ^ Tulp, Martin; Bohlin, Lars (2002). "Functional versus chemical diversity: Is biodiversity important for drug discovery?". Trends in Pharmacological Sciences. 23 (5): 225–31. doi: 10.1016/S0165-6147(02)02007-2. PMID 12008000.
- ^ Cardenas, ME; Cruz, MC; Del Poeta, M; Chung, N; Perfect, JR; Heitman, J (1999). "Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action". Clin. Microbiol. Rev. 12 (4): 583–611. doi: 10.1128/CMR.12.4.583. PMC 88926. PMID 10515904.
- ^ "Discovery of Camptothecin and Taxol - National Historic Chemical Landmark". Archived from the original on 2015-06-20. Retrieved 2015-06-20.
- ^ Syam, Suvitha; Abdul, Ahmad Bustamam; Sukari, Mohd. Aspollah; Mohan, Syam; Abdelwahab, Siddig Ibrahim; Wah, Tang Sook (2011). "The Growth Suppressing Effects of Girinimbine on Hepg2 Involve Induction of Apoptosis and Cell Cycle Arrest". Molecules. 16 (8): 7155–70. doi: 10.3390/molecules16087155. PMC 6264672. PMID 21862957.
- ^ a b "Topotecan (NSC 609699)". National Cancer Institute. Archived from the original on May 27, 2010. Retrieved August 27, 2013.
- ^ "Yew clippings to make chemotherapy". Cancer Research UK. Archived from the original on September 8, 2022. Retrieved August 27, 2013.
- ^ Zarchi, K; Jemec, G. B. (2015). "Ingenol Mebutate: From Common Weed to Cancer Cure". Actinic Keratosis. Current Problems in Dermatology. Vol. 46. pp. 136–42. doi: 10.1159/000366549. ISBN 978-3-318-02762-4. PMID 25561218.
- ^ Peddi, P. F.; Hurvitz, S. A. (2014). "Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: Latest evidence and clinical potential". Therapeutic Advances in Medical Oncology. 6 (5): 202–209. doi: 10.1177/1758834014539183. PMC 4206612. PMID 25342987.